307750 — Kukjeon Pharmaceutical Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapFalling Star

Annual income statement for Kukjeon Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	80,623	85,354	103,711	121,998	136,468
Cost of Revenue
Gross Profit	14,518	17,946	19,515	25,277	21,874
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	74,830	79,219	100,201	115,497	138,790
Operating Profit	5,793	6,135	3,510	6,501	-2,322
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-2,315	5,084	11,088	1,738	879
Provision for Income Taxes
Net Income After Taxes	-3,317	4,038	8,877	4,692	538
Minority Interest
Net Income Before Extraordinary Items
Net Income	-3,317	4,038	8,948	4,824	1,736
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-3,317	4,038	8,948	4,824	1,736
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-92.6	91.5	183	98.3	69.6
Dividends per Share